CardiovascularINJECTIONStandard
CARDIOGEN-82
RUBIDIUM CHLORIDE RB-82
Standard Dose
N/A
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary
Approval overview CARDIOGEN-82 is listed in Drugs@FDA under application 019414 (NDA).
Review priority: PRIORITY Marketing status: Prescription Active ingredient RUBIDIUM CHLORIDE RB-82 Form and strength INJECTABLE;INJECTION - N/A Sponsor BRACCO Submission history Latest submission status date: 2024-12-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview CARDIOGEN-82 is listed in Drugs@FDA under application 019414 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient RUBIDIUM CHLORIDE RB-82 Form and strength INJECTABLE;INJECTION - N/A Sponsor BRACCO Submission history Latest submission status date: 2024-12-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.